Immunicum
Immunicum: Dosing proceeds to the next level (Redeye)
2019-10-02 09:24
In the ongoing ILIAD combination study, the dose escalation committee has given the thumbs up to move on the next dose level of ilixadencel to 10 million cells (3 million cells in the first cohort n=3).
info@redeye.se (Redeye.se)
Redeye AB - Redeye.se